France bleu19d
Addiction aux jeux et au sexe : la descente aux enfers des victimes de médicaments contre la maladie de Parkinson
Cela signifie que dès 2006, GSK est au courant que des recherches sont menées pour découvrir si le Requip pourrait devenir une sorte de nouveau Viagra ... de voir le logo de GSK notamment ...
GSK Stock Up On Q4 Results, Positive Outlook; Plans To Buyback GBP 2 Bln Shares
Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...
Business Insider2d
Barclays Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,405. ...
GSK launches $2.5 billion buyback, lifts sales target after stellar Q4
GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...
FierceBiotech10d
GSK offers up to £50M to conduct cancer vaccine research with the University of Oxford
British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.
Shropshire Star9d
GSK and Oxford researchers to create cancer vaccine to stop disease developing
The University of Oxford and GSK are to work on a vaccine to target cells in the pre-cancerous stage (PA) Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to ...
Fortune27d
GSK, Pfizer RSV shots must warn about rare paralysis risk
Pfizer and GSK vaccines will now be required to carry warnings that they may be tied to an increased risk of a rare neurological side effect. © 2024 Fortune Media IP ...
The Independent9d
Cancer vaccine being created by UK scientists could stop disease up to 20 years early
Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...
Fortune22d
British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
Zonebourse26d
GSK attend l'examen de la FDA pour la présentation d'un nouveau vaccin contre le zona
(Alliance News) - GSK PLC a déclaré vendredi que la Food & Drug Administration des États-Unis avait accepté sa seringue de vaccin Shingrix pour examen. La société pharmaceutique et ...
Yahoo Finance23d
GSK Enters Agreement to Acquire IDRx, Inc.
January 13, 2025--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and IDRx, Inc. (IDRx) today announced that they have entered into an agreement under which GSK will acquire IDRx, a Boston-based ...
FierceBiotech23d
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
In a deal worth up to $1.15 billion, GSK is acquiring precision medicine biotech IDRx and its phase 3-ready gastrointestinal cancer asset. “We really became impressed with what IDRx had achieved ...